Overall rank by patents
#603
Across all tracked assignees
USPTO PatentsView assignee record - 735 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES).
The verdict
Seminis holds 735 US patents across 14 technology areas, rank #603 of 50,000 tracked assignees.
Seminis Vegetable Seeds, Inc. has been granted 735 US utility patents between 2015 and 2025, placing Seminis Vegetable Seeds, Inc. at rank #603 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.6 claims per patent with primary concentration in A01H (NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES). As a US Corporation, Seminis Vegetable Seeds, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Seminis sits between ZOLL Medical Corporation (740 patents, rank #599) and SMC Corporation (728 patents, rank #607) - the closest US assignees by grant volume. The composite Innovation Score of 54.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 356 grants, compared with 379 in the 2015–2019 window, a -6% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Seminis Vegetable Seeds, Inc.'s 22.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Seminis Vegetable Seeds, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ZOLL Medical Corporation
740 patents
Lexmark International, Inc.
737 patents
DENSO International America, Inc.
736 patents
HUSQVARNA AB
736 patents
TOYOTA RESEARCH INSTITUTE, INC.
735 patents
Seminis Vegetable Seeds, Inc.
735 patents
Logitech Europe S.A.
731 patents
MICHELIN RECHERCHE ET TECHNIQUE S.A.
729 patents
SMC CORPORATION
728 patents
What this shows Seminis holds 735 patents at rank #603, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #603 in granted patent volume.
Other assignees with the most granted patents in Seminis's primary technology class.
Seminis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 57 | 7.8% |
| 2016 | 75 | 10.2% |
| 2017 | 94 | 12.8% |
| 2018 | 59 | 8.0% |
| 2019 | 94 | 12.8% |
| 2020 | 78 | 10.6% |
| 2021 | 69 | 9.4% |
| 2022 | 53 | 7.2% |
| 2023 | 67 | 9.1% |
| 2024 | 46 | 6.3% |
| 2025 | 43 | 5.9% |
Top 14 of 14 technology areas
Overall rank by patents
#603
Across all tracked assignees
54.1 out of 100
How to use this portfolio
Seminis's 735 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.